or Try an Advanced Search...

    Technical Analysis for CRSP - CRISPR Therapeutics AG

    Grade Last Price % Change Price Change
    D 53.95 -0.11% -0.06
    CRSP closed down 0.11 percent on Monday, July 1, 2024, on approximately normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    10 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical CRSP trend table...
    Date Alert Name Type % Chg
    Doji - Bullish? Reversal 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Oversold Stochastic Weakness -0.11%
    50 DMA Resistance Bearish -2.58%
    MACD Bearish Centerline Cross Bearish -2.58%
    180 Bearish Setup Bearish Swing Setup -2.58%
    Oversold Stochastic Weakness -2.58%
    50 DMA Resistance Bearish -4.73%
    Oversold Stochastic Weakness -4.73%
    Older End-of-Day Signals for CRSP ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 6 hours ago
    Possible Inside Day about 6 hours ago
    Down 1% about 7 hours ago
    60 Minute Opening Range Breakdown about 7 hours ago
    1.5x Volume Pace about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CRSP Chart by TradingView
    Basic chart:

    Profile

    Crispr Therapeutics AG is a Switzerland-based gene-editing company. The Company focuses on the development of transformative gene-based medicines for serious diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9 gene-editing platform. CRISPR/Cas9 can be programmed to cut, edit and correct disease-associated deoxyribonucleic acid (DNA) in a patient’s cell. The location at which the Cas9 molecular scissors cut the DNA to be edited is specified by guide ribonucleic acid (RNA), which is comprised of a crRNA component and a tracrRNA component, either individually or combined together as a single guide RNA. The Company has business operations in London, the United Kingdom, as well as research and development operations in Cambridge, the United States.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Immune System Acid Genetics Enzymes Genetic Engineering Precision Medicine DNA CRISPR Genome Editing Cas9

    Is CRSP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Is CRISPR Therapeutics Stock a Buy? One Analyst Thinks the Biotech Is "Very Undervalued."
    Jun 26 CRISPR Therapeutics AG (CRSP) Surpasses Market Returns: Some Facts Worth Knowing
    Jun 25 3 Gene Editing Stocks That Could Make Your Grandchildren Rich
    Jun 24 Is Most-Watched Stock CRISPR Therapeutics AG (CRSP) Worth Betting on Now?
    Jun 20 CRISPR Therapeutics AG (CRSP) Registers a Bigger Fall Than the Market: Important Facts to Note
    Jun 19 CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
    Jun 12 7 ‘FIRE’ Stocks to Put You on the Path to Financial Freedom
    Jun 11 CRISPR Therapeutics (CRSP) Presents at Goldman Sachs 45th Annual Global Healthcare Conference - Company Call Transcript
    Jun 11 CRISPR Therapeutics AG (CRSP) is Attracting Investor Attention: Here is What You Should Know
    Jun 10 Crispr Therapeutics, Futurism-Turning-Commercial, Defies 'Valuation' (Technical Analysis)
    See more CRSP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 91.1
    52 Week Low 37.55
    Average Volume 1,348,851
    200-Day Moving Average 60.48
    50-Day Moving Average 56.59
    20-Day Moving Average 59.05
    10-Day Moving Average 57.21
    Average True Range 2.73
    RSI (14) 39.39
    ADX 18.19
    +DI 18.26
    -DI 27.64
    Chandelier Exit (Long, 3 ATRs) 59.68
    Chandelier Exit (Short, 3 ATRs) 61.51
    Upper Bollinger Bands 65.53
    Lower Bollinger Band 52.56
    Percent B (%b) 0.11
    BandWidth 21.96
    MACD Line -0.72
    MACD Signal Line 0.13
    MACD Histogram -0.8516
    Fundamentals Value
    Market Cap 4.29 Billion
    Num Shares 79.4 Million
    EPS -4.47
    Price-to-Earnings (P/E) Ratio -12.07
    Price-to-Sales 34.65
    Price-to-Book 3.22
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 57.49
    Resistance 3 (R3) 57.67 56.67 56.90
    Resistance 2 (R2) 56.67 55.77 56.58 56.70
    Resistance 1 (R1) 55.31 55.21 54.81 55.13 56.51
    Pivot Point 54.31 54.31 54.06 54.22 54.31
    Support 1 (S1) 52.95 53.41 52.45 52.77 51.39
    Support 2 (S2) 51.95 52.85 51.86 51.20
    Support 3 (S3) 50.59 51.95 51.00
    Support 4 (S4) 50.41